Multicenter Phase 2 Study of Oral azacitidine (CC-486) plus CHOP as initial treatment for peripheral T-cell lymphomaJia Ruan, Peter W. Martin, Zhengming Chen et al.|Blood|2023Cited by 47
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell LymphomaFrancine M. Foss, Madeleine Duvic, Youn H. Kim et al.|Journal of Clinical Oncology|2024Cited by 22